Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Director/PDMR Shareholding

4 Apr 2012 11:57

Interserve Plc Notification of Transactions of Directors/ Persons Discharging Managerial Responsibility and Connected Persons

Pursuant to Disclosure and Transparency Rule 3.1.2, Interserve Plc (the "Company") announces that it was informed on 3 April 2012 by EES Trustees International Limited, in its capacity as Trustee of the Interserve Employee Benefit Trust, that the following ordinary shares of 10p each in the Company were transferred for no consideration to certain Executive Directors/Person Discharging Managerial Responsibilities ("PDMR") on 23 March 2012 pursuant to the Interserve Plc Performance Share Plan 2006. The number of shares vested was subject to the satisfaction of certain performance conditions over a three-year period based on earnings per share and total shareholder return.

Executive Directors

1. 61,576 shares acquired by Mr Steven Dance (0.049% of issued share capital). 27,005 shares were disposed of at an average share price of ÂŁ2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Dance now has an interest in 99,534 ordinary shares of 10p each in the Company (0.079%% of issued share capital).

2. 61,576 shares acquired by Mr Bruce Melizan (0.049% of issued share capital). 27,005 shares were disposed of at an average share price of ÂŁ2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Melizan now has an interest in 100,521 ordinary shares of 10p each in the Company (0.079% of issued share capital).

3. 51,724 shares acquired by Mr David Paterson (0.041% of issued share capital). 22,684 shares were disposed of at an average share price of ÂŁ2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Paterson now has an interest in 46,975 ordinary shares of 10p each in the Company (0.037% of issued share capital).

4. 103,448 shares acquired by Mr Adrian Ringrose (0.082% of issued share capital). 45,368 shares were disposed of at an average share price of ÂŁ2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Ringrose now has an interest in 263,060 ordinary shares of 10p each in the Company (0.208% of issued share capital).

5. 45,300 shares acquired by Mr Douglas Sutherland (0.036% of issued share capital). 19,867 shares were disposed of at an average share price of ÂŁ2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Sutherland now has an interest in 51,408 ordinary shares of 10p each in the Company (0.041% of issued share capital).

PDMR

1. 37,006 shares acquired by Mr Trevor Bradbury (0.029% of issued share capital). 16,230 shares were disposed of at an average share price of ÂŁ2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Bradbury now has an interest in 62,287 ordinary shares of 10p each in the Company (0.049% of issued share capital).

4 April 2012Trevor BradburyGroup SecretaryTel: 0118 932 0123

PINX
Date   Source Headline
21st Aug 20182:16 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSInterserve wins £105m Durham University project
16th Aug 20183:55 pmRNSDirector/PDMR Shareholding
14th Aug 20189:04 amRNSHolding(s) in Company
13th Aug 20189:00 amRNSHolding(s) in Company
7th Aug 20187:00 amRNSHalf-year Report
1st Aug 20187:00 amRNSInterserve wins £67m contract
31st Jul 20188:57 amRNSHolding(s) in Company
20th Jul 201812:45 pmRNSDirector Declaration
16th Jul 20189:35 amRNSDirector/PDMR Shareholding
13th Jul 20188:44 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSInterserve wins £35m contract
10th Jul 20184:29 pmRNSHolding(s) in Company
3rd Jul 20181:17 pmRNSHolding(s) in Company
2nd Jul 201812:23 pmRNSHolding(s) in Company
2nd Jul 201810:33 amRNSBlock listing Interim Review
27th Jun 20183:25 pmRNSDirector/PDMR Shareholding
26th Jun 20187:00 amRNSDirectorate Change
12th Jun 20183:20 pmRNSResult of AGM
11th Jun 201812:04 pmRNSDirector/PDMR Shareholding
6th Jun 20183:44 pmRNSHolding(s) in Company
6th Jun 201812:04 pmRNSDirector/PDMR Shareholding
5th Jun 201811:09 amRNSHolding(s) in Company
5th Jun 20189:36 amRNSInterserve agrees sale of Haymarket
31st May 20183:19 pmRNSHolding(s) in Company
31st May 20183:15 pmRNSTotal Voting Rights
30th May 20183:15 pmRNSHolding(s) in Company
29th May 201810:35 amRNSHolding(s) in Company
24th May 201810:12 amRNSHolding(s) in Company
21st May 201812:17 pmRNSHolding(s) in Company
18th May 20189:50 amRNSHolding(s) in Company
17th May 20183:34 pmRNSHolding(s) in Company
17th May 20189:28 amRNSHolding(s) in Company
16th May 20182:33 pmRNSTotal Voting Rights
14th May 20183:17 pmRNSBlock Listing Application
14th May 201810:13 amRNSHolding(s) in Company
11th May 20189:21 amRNSAnnual Report and Financials Publication 2017
11th May 20187:00 amRNSFCA Notification
10th May 201811:37 amRNSDirector/PDMR Shareholding
10th May 201810:42 amRNSDirector/PDMR Shareholding
10th May 20188:40 amRNSHolding(s) in Company
9th May 201810:56 amRNSHolding(s) in Company
8th May 201810:31 amRNSHolding(s) in Company
4th May 20184:10 pmRNSDirector/PDMR Shareholding
3rd May 20184:04 pmRNSDirector/PDMR Shareholding
2nd May 20184:21 pmRNSHolding(s) in Company
1st May 201811:33 amRNSDirector/PDMR Shareholding
30th Apr 20187:10 amRNSDirectorate Change
30th Apr 20187:00 amRNSFinal Results
27th Apr 20181:21 pmRNSSigning of Group Refinancing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.